Image 1 of 1
Retatrutide 15 MG
Retatrutide is a peptide that acts as a multi-receptor agonist targeting the GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. By activating these three metabolic pathways simultaneously, retatrutide helps regulate blood glucose levels, influence energy balance, and support overall metabolic efficiency. Through its GLP-1 and GIP activity, it stimulates insulin secretion in response to food intake, helps reduce glucagon release when appropriate, and promotes satiety by signaling fullness to the brain. At the same time, glucagon receptor activation can increase energy expenditure and influence how the body utilizes stored fat, contributing to improved metabolic regulation.
Beyond glucose control, retatrutide also supports broader metabolic processes related to weight management and energy balance. Its combined receptor activity may help enhance insulin sensitivity, support appetite regulation, and promote more efficient use of energy within the body. By influencing appetite control, nutrient processing, and metabolic function simultaneously, retatrutide contributes to maintaining metabolic balance and supporting overall health and wellness.
Please be advised: All compounds and research materials provided by National Biosciences Group are strictly for laboratory and research use only. They are not approved for human consumption by the Food and Drug Administration (FDA). These products should not be used for any form of in vivo experimentation or for any other non-laboratory purpose. By purchasing these products, you acknowledge that they will be used exclusively within a controlled and qualified research environment.
The material contained on this website is not intended to be medical or research advice, does not constitute a solicitation to engage our services or form a professional-client relationship, and is not provided in a fiduciary capacity.
This material is provided for informational purposes only and is not intended to be relied upon as medical advice, research guidance, or a recommendation to pursue any specific research strategy or course of action. The opinions expressed are subject to change at any time without notice. References to specific research matters, methodologies, studies, or data are for illustrative purposes only and are not intended to be and should not be interpreted as recommendations or endorsements. The information provided does not take into account the specific objectives or circumstances of any particular individual or entity, or suggest any specific course of action.
FOR INSTITUTIONAL, PROFESSIONAL, AND PERMITTED CLIENT USE ONLY. THIS MATERIAL IS NOT TO BE REPRODUCED OR DISTRIBUTED TO PERSONS OTHER THAN THE RECIPIENT.
National Biosciences Group is an innovative, multidisciplinary research firm advising a diverse portfolio of clients across North America. We specialize in complex biopharmaceutical, scientific, and regulatory matters, as well as complementary practices that demand strategic, cross-disciplinary insight and flawless execution.
NOT MEDICAL ADVICE PRIOR RESULTS DO NOT GUARANTEE A SIMILAR OUTCOME.
Retatrutide is a peptide that acts as a multi-receptor agonist targeting the GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. By activating these three metabolic pathways simultaneously, retatrutide helps regulate blood glucose levels, influence energy balance, and support overall metabolic efficiency. Through its GLP-1 and GIP activity, it stimulates insulin secretion in response to food intake, helps reduce glucagon release when appropriate, and promotes satiety by signaling fullness to the brain. At the same time, glucagon receptor activation can increase energy expenditure and influence how the body utilizes stored fat, contributing to improved metabolic regulation.
Beyond glucose control, retatrutide also supports broader metabolic processes related to weight management and energy balance. Its combined receptor activity may help enhance insulin sensitivity, support appetite regulation, and promote more efficient use of energy within the body. By influencing appetite control, nutrient processing, and metabolic function simultaneously, retatrutide contributes to maintaining metabolic balance and supporting overall health and wellness.
Please be advised: All compounds and research materials provided by National Biosciences Group are strictly for laboratory and research use only. They are not approved for human consumption by the Food and Drug Administration (FDA). These products should not be used for any form of in vivo experimentation or for any other non-laboratory purpose. By purchasing these products, you acknowledge that they will be used exclusively within a controlled and qualified research environment.
The material contained on this website is not intended to be medical or research advice, does not constitute a solicitation to engage our services or form a professional-client relationship, and is not provided in a fiduciary capacity.
This material is provided for informational purposes only and is not intended to be relied upon as medical advice, research guidance, or a recommendation to pursue any specific research strategy or course of action. The opinions expressed are subject to change at any time without notice. References to specific research matters, methodologies, studies, or data are for illustrative purposes only and are not intended to be and should not be interpreted as recommendations or endorsements. The information provided does not take into account the specific objectives or circumstances of any particular individual or entity, or suggest any specific course of action.
FOR INSTITUTIONAL, PROFESSIONAL, AND PERMITTED CLIENT USE ONLY. THIS MATERIAL IS NOT TO BE REPRODUCED OR DISTRIBUTED TO PERSONS OTHER THAN THE RECIPIENT.
National Biosciences Group is an innovative, multidisciplinary research firm advising a diverse portfolio of clients across North America. We specialize in complex biopharmaceutical, scientific, and regulatory matters, as well as complementary practices that demand strategic, cross-disciplinary insight and flawless execution.
NOT MEDICAL ADVICE PRIOR RESULTS DO NOT GUARANTEE A SIMILAR OUTCOME.